We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$51.8B
AUM Growth
+$2.19B
Cap. Flow
-$1.04B
Cap. Flow %
-2.01%
Top 10 Hldgs %
17.67%
Holding
2,975
New
68
Increased
781
Reduced
1,984
Closed
53

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$102M
2
XL
XL Group Ltd.
XL
+$28.4M
3
MSFT icon
Microsoft
MSFT
+$26.9M
4
CSCO icon
Cisco
CSCO
+$24.2M
5
GGP
GGP Inc.
GGP
+$24M

Sector Composition

Rank Sector Weight
1 Technology 18.16%
2 Financials 15.87%
3 Healthcare 13.94%
4 Consumer Discretionary 10.36%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMRE icon
2501
Costamare
CMRE
$1.8B
$310K ﹤0.01%
47,778
+408
+0.9% +$2.91K
IIPR icon
2502
Innovative Industrial Properties
IIPR
$1.69B
$310K ﹤0.01%
6,435
+185
+3% +$7.07K
SGRY icon
2503
Surgery Partners
SGRY
$1.95B
$310K ﹤0.01%
18,787
-150
-0.8% -$2.39K
BATRA icon
2504
Atlanta Braves Holdings Series A
BATRA
$3.37B
$307K ﹤0.01%
11,259
-625
-5% -$16.3K
NKSH icon
2505
National Bankshares
NKSH
$266M
$307K ﹤0.01%
6,747
+103
+2% +$4.79K
SIGA icon
2506
SIGA Technologies
SIGA
$224M
$307K ﹤0.01%
44,562
-2,961
-6% -$21.7K
HCCI
2507
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$307K ﹤0.01%
14,383
+75
+0.5% +$1.64K
ALBO
2508
DELISTED
Albireo Pharma Inc
ALBO
$307K ﹤0.01%
9,313
-125
-1% -$4.09K
ZIXI
2509
DELISTED
Zix Corporation
ZIXI
$305K ﹤0.01%
54,981
-3,425
-6% -$19K
AVEO
2510
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$304K ﹤0.01%
9,196
-68
-0.7% -$1.75K
CASA
2511
DELISTED
Casa Systems, Inc. Common Stock
CASA
$303K ﹤0.01%
20,532
+7,485
+57% +$114K
CATC
2512
DELISTED
CAMBRIDGE BANCORP
CATC
$302K ﹤0.01%
3,355
+1
+0% +$90
TITN icon
2513
Titan Machinery
TITN
$448M
$300K ﹤0.01%
19,343
+445
+2% +$7.04K
CDMO
2514
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$300K ﹤0.01%
43,756
-668
-2% -$3.96K
HRTG icon
2515
Heritage Insurance Holdings
HRTG
$1.07B
$299K ﹤0.01%
20,204
-35
-0.2% -$552
SNAP icon
2516
Snap
SNAP
$8.83B
$299K ﹤0.01%
35,281
ABB
2517
DELISTED
ABB Ltd
ABB
$299K ﹤0.01%
+12,657
New +$290K
MCBC
2518
DELISTED
Macatawa Bank Corp
MCBC
$297K ﹤0.01%
25,384
-100
-0.4% -$1.23K
BSTC
2519
DELISTED
BioSpecifics Technologies Corp.
BSTC
$295K ﹤0.01%
5,038
-300
-6% -$15.3K
CHMI
2520
Cherry Hill Mortgage Investment Corp
CHMI
$87.8M
$294K ﹤0.01%
16,220
+2,186
+16% +$40.1K
ECOM
2521
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$294K ﹤0.01%
23,601
-8,575
-27% -$114K
NPTN
2522
DELISTED
NEOPHOTONICS CORP
NPTN
$294K ﹤0.01%
35,424
+610
+2% +$4.64K
YELL
2523
DELISTED
Yellow Corporation Common Stock
YELL
$294K ﹤0.01%
32,691
-450
-1% -$4.37K
OPY icon
2524
Oppenheimer Holdings
OPY
$1.22B
$292K ﹤0.01%
9,229
KERX
2525
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$292K ﹤0.01%
85,756
-6,075
-7% -$21.9K

Similar funds

RhumbLine Advisers's Q3 2018 Portfolio in Review

As of Q3 2018, RhumbLine Advisers held 2,975 positions worth $51.8B, up 4.4% from $49.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q3 2018: portfolio turnover was 4.1%. RhumbLine Advisers opened 68 new positions and exited 53, leaving the 2,975-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2018 buy was iShares TIPS Bond ETF: 312,303 shares worth $34.5M.
  • RhumbLine Advisers added most to Williams Companies in Q3 2018, an estimated $16.4M increase.
  • RhumbLine Advisers's biggest Q3 2018 reduction was Apple, cutting an estimated $102M.
  • RhumbLine Advisers fully exited XL Group Ltd. in Q3 2018, selling an estimated $28.4M.
  • RhumbLine Advisers's ten largest holdings make up 18% of its $51.8B portfolio in Q3 2018.
  • RhumbLine Advisers opened 68 new positions and closed 53 in Q3 2018.
  • RhumbLine Advisers's portfolio value rose 4.4% quarter-over-quarter to $51.8B.

Based on RhumbLine Advisers's 13F filing for Q3 2018, filed 7 Nov 2018.